Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.
Thromb Res
; 216: 125-128, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-34969528
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tissue Plasminogen Activator
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Thromb Res
Year:
2022
Document type:
Article